Addex Therapeutics Ltd Estimated Financial Effect Of Contingent Liabilities
Addex Therapeutics Ltd (ADXN) had Estimated Financial Effect Of Contingent Liabilities of CHF 0 as of 2024-12-31, per its 20-F filed 2025-05-15.
Financial Statements › Notes
ifrs-full:EstimatedFinancialEffectOfContingentLiabilities · last filed 2025-05-15
- 2024-12-31: Estimated Financial Effect Of Contingent Liabilities 0.00 CHF.
- 2023-12-31: Estimated Financial Effect Of Contingent Liabilities 0.00 CHF.
- 2022-12-31: Estimated Financial Effect Of Contingent Liabilities 0.00 CHF.
- 2021-12-31: Estimated Financial Effect Of Contingent Liabilities 0.00 CHF.
| Period end | Estimated Financial Effect Of Contingent Liabilities |
|---|---|
| 2024-12-31 | 0.00 CHF 20-F · filed 2025-05-15 |
| 2023-12-31 | 0.00 CHF 20-F · filed 2024-04-18 |
| 2022-12-31 | 0.00 CHF 20-F · filed 2023-03-30 |
| 2021-12-31 | 0.00 CHF 20-F · filed 2022-03-10 |
| 2020-12-31 | 0.00 CHF 20-F · filed 2021-03-11 |
| 2019-12-31 | 0.00 CHF 20-F · filed 2020-04-27 |